Interestingly, we observed that high MSI2 expression was associated with poor OS in MCL patients, independently of other high-risk factors, like SOX11 expression, high CNA, TP53 and CDKN2A alterations. The gene discussed is TP53; the disease is mantle cell lymphoma.